My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Curonix LLC
Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso
September 18, 2025
From
Curonix LLC
Via
GlobeNewswire
Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy
March 27, 2025
From
Curonix LLC
Via
GlobeNewswire
Curonix leads the PNS market with expanded MR Labeling for 3T Full-Body MRI Scans for its Freedom® Peripheral Nerve Stimulator (PNS) System
January 30, 2025
From
Curonix LLC
Via
GlobeNewswire
Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain
December 04, 2024
From
Curonix LLC
Via
GlobeNewswire
Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System
July 09, 2024
From
Curonix LLC
Via
GlobeNewswire
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024
From
Curonix LLC
Via
GlobeNewswire
Curonix Celebrates 1st Anniversary
November 01, 2023
From
Curonix LLC
Via
GlobeNewswire
Retrospective clinical study highlights the effectiveness of Curonix’s Freedom® PNS System in reducing pain scores and improving patient satisfaction
August 10, 2023
From
Curonix LLC
Via
GlobeNewswire
Curonix Provides Reimbursement Update on Neurostimulator Procedure Codes
July 18, 2023
From
Curonix LLC
Via
GlobeNewswire
Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage
June 07, 2023
From
Curonix LLC
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.